Condition
Hepatic Encephalopathy (HE)
Total Trials
6
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 2 (1)
Trial Status
Not Yet Recruiting4
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07429838Phase 1Not Yet Recruiting
EGEN-5784 Porcine Liver With the Metra® ELC Device
NCT07349654Not ApplicableRecruiting
Underdilated-stent Technique Improves Post-TIPS Encephalopathy
NCT07273734Not ApplicableNot Yet RecruitingPrimary
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
NCT07150195Not Yet Recruiting
Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)
NCT06923254Not Yet RecruitingPrimary
7.0T Magnetic Resonance Imaging Study for Hepatic Encephalopathy
NCT03712280Phase 2Completed
MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)
Showing all 6 trials